{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:15:11Z","timestamp":1788048911394,"version":"build-2784847793"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clim.2026.110747","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:26:19Z","timestamp":1783628779000},"page":"110747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunopathogenesis of NMDA receptor encephalitis"],"prefix":"10.1016","volume":"287","author":[{"given":"\u03a4heodoros","family":"Dame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Themas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elpida","family":"Repousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios C.","family":"Constantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Koros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokratis G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110747_bb0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0010","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.19925.1","article-title":"NMDA receptor C-terminal signaling in development, plasticity, and disease","volume":"8","author":"Hardingham","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.clim.2026.110747_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1871527319666200708133103","article-title":"Autoimmune encephalitis: current knowledge on subtypes, disease mechanisms and treatment","volume":"19","author":"Nissen","year":"2020","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.clim.2026.110747_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12883-021-02232-6","article-title":"Autoimmune encephalitis in a south Asian population","volume":"21","author":"Wickramasinghe","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.clim.2026.110747_bb0045","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10096-009-0799-0","article-title":"Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis","volume":"28","author":"Gable","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.clim.2026.110747_bb0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0055","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00415-021-10738-9","article-title":"NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study","volume":"269","author":"Nissen","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/ppc.12132","article-title":"Biological perspectives: anti-NMDA receptor encephalitis","volume":"51","author":"Dowben","year":"2015","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.clim.2026.110747_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00389","article-title":"Experimental models of Neuroimmunological disorders: a review","volume":"11","author":"da Silva","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.clim.2026.110747_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PRA.0000000000000603","article-title":"Anti-NMDA receptor encephalitis masquerades as psychosis: a case report","volume":"28","author":"Giri","year":"2022","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.clim.2026.110747_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00737-018-0816-3","article-title":"Anti-NMDA receptor encephalitis presenting as postpartum psychosis-a clinical description and review","volume":"21","author":"Reddy","year":"2018","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.clim.2026.110747_bb0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pcl.2023.01.007","article-title":"Evaluation, treatment, and outcomes of viral and autoimmune encephalitis in children","volume":"70","author":"Vova","year":"2023","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.clim.2026.110747_bb0090","article-title":"Neural autoantibodies in cerebrospinal fluid and serum in clinical High risk for psychosis, first-episode psychosis, and healthy volunteers","volume":"12","author":"Bien","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.clim.2026.110747_bb0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41398-021-01701-3","article-title":"Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis","volume":"11","author":"Theorell","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0100","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, Neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00442","article-title":"Hello from the other side: how autoantibodies circumvent the blood\u2013brain barrier in autoimmune encephalitis","volume":"8","author":"Platt","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0110","first-page":"2641","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis, brain","volume":"139","author":"Kreye","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118281","article-title":"Altered EEG markers of synaptic plasticity in a human model of NMDA receptor deficiency: anti-NMDA receptor encephalitis","volume":"239","author":"Gefferie","year":"2021","journal-title":"NeuroImage"},{"key":"10.1016\/j.clim.2026.110747_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","article-title":"In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction","volume":"5","author":"Manto","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.clim.2026.110747_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00178","article-title":"An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis","volume":"10","author":"Amedonu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-021-06036-x","article-title":"Impairment of early neuronal maturation in anti-NMDA-receptor encephalitis","volume":"239","author":"Okamoto","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.clim.2026.110747_bb0140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.clim.2026.110747_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/B978-0-12-823912-4.00019-0","article-title":"Paraneoplastic encephalitis","volume":"200","author":"Casagrande","year":"2024","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijgo.16028","article-title":"Anti-NMDA receptor autoimmune encephalitis associated with ovarian teratoma: a case series and literature review","volume":"169","author":"Nha","year":"2025","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"key":"10.1016\/j.clim.2026.110747_bb0160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0165","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ebcr.2015.07.005","article-title":"Anti-NMDA-receptor antibody encephalitis in infants","volume":"4","author":"Matoq","year":"2015","journal-title":"Epilepsy Behav. Case Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578139","article-title":"Infectious profiles in pediatric anti-N-methyl-d-aspartate receptor encephalitis","volume":"381","author":"Sandweiss","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/YCO.0000000000000846","article-title":"Neuroinflammatory syndromes in children","volume":"36","author":"Hauptman","year":"2023","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: a cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0200","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clim.2026.110747_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ph17101265","article-title":"NMDA receptors: distribution, role, and insights into neuropsychiatric disorders","volume":"17","author":"Beaurain","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clim.2026.110747_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686466","article-title":"Short- and Long-lived autoantibody-secreting cells in autoimmune neurological disorders","volume":"12","author":"Zografou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/IJGM.S397429","article-title":"Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies","volume":"16","author":"Nguyen","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.clim.2026.110747_bb0220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/brainsci15050518","article-title":"Anti-NMDA receptor encephalitis: a narrative review","volume":"15","author":"P\u0103dureanu","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.clim.2026.110747_bb0225","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1212\/CPJ.0000000000001001","article-title":"High-dose diazepam controls severe dyskinesia in anti-NMDA receptor encephalitis","volume":"11","author":"Shin","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.clim.2026.110747_bb0230","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/epd2.20231","article-title":"Autoimmune-associated seizure disorders","volume":"26","author":"Smith","year":"2024","journal-title":"Epileptic Disord. Int. Epilepsy J. Videotape"},{"key":"10.1016\/j.clim.2026.110747_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.609750","article-title":"Clinical study of autonomic dysfunction in patients with anti-NMDA receptor encephalitis","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaclp.2023.12.002","article-title":"Examining the features of neuroleptic malignant syndrome in anti-NMDA receptor encephalitis: a case-control study","volume":"65","author":"Ramirez-Bermudez","year":"2024","journal-title":"J. Acad. Consult Liaison Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0245","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/acn3.467","article-title":"Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis","volume":"4","author":"Jun","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0250","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000812","article-title":"Catatonia in anti-NMDA receptor encephalitis: a case series and approach to improve outcomes with electroconvulsive therapy","volume":"6","author":"Kraiter","year":"2024","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.clim.2026.110747_bb0255","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210109","article-title":"Long-term cognitive, functional, and patient-reported outcomes in patients with anti-NMDAR encephalitis","volume":"103","author":"Brenner","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0260","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000958","article-title":"Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis","volume":"8","author":"Gong","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578651","article-title":"An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: analysis, equipoise, and the urgent need for evidence over anecdote","volume":"405","author":"Hoshina","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0270","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0275","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200421","article-title":"Relapses in anti-NMDAR encephalitis","volume":"12","author":"Ciano-Petersen","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0280","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/dmcn.14267","article-title":"Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis","volume":"61","author":"Nosadini","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0285","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00415-021-10828-8","article-title":"Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"269","author":"Hirose","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0300","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neurol.2024.08.006","article-title":"MRI findings in autoimmune encephalitis","volume":"180","author":"Hartung","year":"2024","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.clim.2026.110747_bb0305","first-page":"54","article-title":"Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review","volume":"52","author":"Bacchi","year":"2018","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.clim.2026.110747_bb0310","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000413","article-title":"Decreased occipital lobe metabolism by FDG-PET\/CT: An anti-NMDA receptor encephalitis biomarker","volume":"5","author":"Probasco","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0315","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/cns.14125","article-title":"Hypometabolism of the left middle\/medial frontal lobe on FDG-PET in anti-NMDA receptor encephalitis: comparison with MRI and EEG findings","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clim.2026.110747_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.remnie.2025.500084","article-title":"Striking pattern on [18F]FDG PET\/CT in anti-NMDA receptor encephalitis","volume":"44","author":"L\u00f3pez-Mora","year":"2025","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"},{"key":"10.1016\/j.clim.2026.110747_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313127","article-title":"Current status of biomarkers in anti-N-methyl-D-aspartate receptor encephalitis","volume":"22","author":"Ciano-Petersen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb0330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","article-title":"Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease","volume":"83","author":"Leypoldt","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis - a systematic review","volume":"65","author":"Gillinder","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.clim.2026.110747_bb0340","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236340","article-title":"Anti-NMDA receptor encephalitis in an adolescent with a cryptic ovarian teratoma","volume":"14","author":"Walker","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0350","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0355","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00234-024-03318-x","article-title":"Autoimmune encephalitis: what the radiologist needs to know","volume":"66","author":"Sanvito","year":"2024","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clim.2026.110747_bb0360","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.molmed.2025.09.005","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions","volume":"32","author":"Hoshina","year":"2026","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clim.2026.110747_bb0365","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0370","first-page":"1","article-title":"Recent advances in autoimmune encephalitis","volume":"82","author":"Ferreira","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.clim.2026.110747_bb0375","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.clim.2026.110747_bb0380","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.0802075105","article-title":"Rules of engagement for NMDA receptor subunits","volume":"105","author":"Ulbrich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2026.110747_bb0385","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1523\/JNEUROSCI.19-18-07781.1999","article-title":"Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit","volume":"19","author":"Okabe","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0390","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.celrep.2019.11.087","article-title":"Control of Long-term synaptic potentiation and learning by alternative splicing of the NMDA receptor subunit GluN1","volume":"29","author":"Sengar","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0395","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s11064-010-0145-z","article-title":"Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study","volume":"35","author":"Vrajov\u00e1","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.clim.2026.110747_bb0400","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/dneu.20844","article-title":"Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneurons","volume":"71","author":"Zhang","year":"2011","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.clim.2026.110747_bb0405","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature04089","article-title":"Subunit arrangement and function in NMDA receptors","volume":"438","author":"Furukawa","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2026.110747_bb0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2006.01.051","article-title":"Differential expression of the NMDA NR2B receptor subunit in motoneuron populations susceptible and resistant to amyotrophic lateral sclerosis","volume":"399","author":"Fuller","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2026.110747_bb0415","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2007.09.008","article-title":"Analysis of NR3A receptor subunits in human native NMDA receptors","volume":"1186","author":"Nilsson","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.clim.2026.110747_bb0420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3940(01)02524-1","article-title":"Cloning and expression of the human N-methyl-D-aspartate receptor subunit NR3A","volume":"321","author":"Eriksson","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2026.110747_bb0425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12035-008-8029-9","article-title":"Shuffling the deck anew: how NR3 tweaks NMDA receptor function","volume":"38","author":"Cavara","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.clim.2026.110747_bb0430","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0166-2236(89)90042-8","article-title":"Glycine modulation of the NMDA receptor\/channel complex","volume":"12","author":"Thomson","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0435","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2025.2490308","article-title":"The GluN3-containing NMDA receptors","volume":"19","author":"Xiong","year":"2025","journal-title":"Channels"},{"key":"10.1016\/j.clim.2026.110747_bb0440","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn.2016.92","article-title":"Emerging roles of GluN3-containing NMDA receptors in the CNS","volume":"17","author":"P\u00e9rez-Ota\u00f1o","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0445","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.str.2018.05.004","article-title":"Glutamate and Glycine binding to the NMDA receptor","volume":"26","author":"Yu","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.clim.2026.110747_bb0450","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.clim.2026.110747_bb0455","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0460","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pnpbp.2018.11.017","article-title":"Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder","volume":"90","author":"Burket","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0465","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.neuropharm.2011.12.029","article-title":"Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations","volume":"62","author":"Nikolaev","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clim.2026.110747_bb0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1113\/jphysiol.2014.273763","article-title":"Molecular bases of NMDA receptor subtype-dependent properties","volume":"593","author":"Glasgow","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.clim.2026.110747_bb0475","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.clim.2026.110747_bb0480","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1515\/revneuro-2022-0096","article-title":"Targeting NMDA receptor signaling for therapeutic intervention in brain disorders","volume":"34","author":"Chen","year":"2023","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0485","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5093048","article-title":"NMDA receptor subunits change after synaptic plasticity induction and learning and memory acquisition","volume":"2018","author":"Baez","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.clim.2026.110747_bb0490","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986712799462685","article-title":"NAAG, NMDA receptor and psychosis","volume":"19","author":"Bergeron","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clim.2026.110747_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212366","article-title":"NMDA Receptors in neurodevelopmental disorders: pathophysiology and disease models","volume":"25","author":"Tumdam","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-026-10278-0","article-title":"Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity","author":"Kleeman","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.clim.2026.110747_bb0505","first-page":"404","article-title":"Autoimmune encephalitis: NMDA receptor encephalitis as an example of translational neuroscience","volume":"17","author":"Kolls","year":"2020","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.clim.2026.110747_bb0510","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awaa250","article-title":"Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor","volume":"143","author":"Wagnon","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0515","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.mayocp.2021.07.023","article-title":"Autoimmune\/paraneoplastic encephalitis antibody biomarkers: frequency, age, and sex associations","volume":"97","author":"Kunchok","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clim.2026.110747_bb0520","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0525","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0530","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0535","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/glia.24369","article-title":"Microglia actively remove NR1 autoantibody-bound NMDA receptors and associated post-synaptic proteins in neuron microglia co-cultures","volume":"71","author":"Rahman","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.clim.2026.110747_bb0540","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ana.23626","article-title":"Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain","volume":"72","author":"Kaindl","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0545","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1016\/j.ymthe.2025.08.001","article-title":"Harnessing patient-derived antibodies-induced microglial complement 1q expression: novel therapy for anti-NMDAR encephalitis","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2026.110747_bb0550","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4103\/1673-5374.322423","article-title":"Microglia regulation of synaptic plasticity and learning and memory","volume":"17","author":"Cornell","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.clim.2026.110747_bb0555","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types","volume":"1","author":"Doss","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0560","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0565","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","article-title":"IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment","volume":"78","author":"Pr\u00fcss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0570","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41594-024-01386-4","article-title":"Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis","volume":"31","author":"Michalski","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.clim.2026.110747_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577427","article-title":"Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B","volume":"349","author":"Takahashi","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0580","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","article-title":"NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA Receptors","volume":"23","author":"Lad\u00e9p\u00eache","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0585","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.1689-21.2022","article-title":"Patient-derived anti-NMDAR antibody disinhibits cortical neuronal networks through dysfunction of inhibitory neuron output","volume":"42","author":"Andrzejak","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0590","first-page":"1812","article-title":"NMDA-receptor-fc-fusion constructs neutralize anti-NMDA receptor antibodies, brain","volume":"146","author":"Steinke","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0595","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12821","article-title":"Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies","volume":"292","author":"Meffre","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2026.110747_bb0600","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0605","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2026.110747_bb0610","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2026.110747_bb0615","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/eji.201847517","article-title":"Plasma cells: the programming of an antibody-secreting machine","volume":"49","author":"Tellier","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0620","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","article-title":"Memory B cells of mice and humans","volume":"35","author":"Weisel","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0625","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers15061791","article-title":"The BAFF-APRIL system in cancer","volume":"15","author":"Ullah","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clim.2026.110747_bb0630","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0635","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-0716-4184-2_2","article-title":"Tertiary lymphoid structures in central nervous system disorders","volume":"2864","author":"Vaccaro","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2026.110747_bb0640","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/eji.200737784","article-title":"Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies","volume":"38","author":"von B\u00fcdingen","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0645","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00415-025-12907-6","article-title":"CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective","volume":"272","author":"Di Sabatino","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0650","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneuroim.2011.01.010","article-title":"Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin","volume":"233","author":"Obermeier","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0655","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2007.05.002","article-title":"BAFF, APRIL, TWE-PRIL: who's who?","volume":"7","author":"Daridon","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2026.110747_bb0660","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0665","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2017.01.012","article-title":"Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: correlation with clinical outcome","volume":"305","author":"Deng","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0670","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamaneurol.2013.585","article-title":"Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis","volume":"70","author":"Hansen","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0675","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","article-title":"Brain immunohistopathological study in a patient with anti-NMDAR encephalitis","volume":"18","author":"Camdessanch\u00e9","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0680","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034237","article-title":"Abundant infiltration of B cells and plasma cells in brain biopsy of a male patient with severe anti-NMDA receptor encephalitis: a case report","volume":"102","author":"Wei","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2026.110747_bb0685","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.26223","article-title":"Neuropathological variability within a Spectrum of NMDAR-encephalitis","volume":"90","author":"Zrzavy","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0690","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.clim.2026.110747_bb0695","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0700","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/acn3.444","article-title":"NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody","volume":"4","author":"Malviya","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0705","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0044","article-title":"Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors","volume":"11","author":"Jones","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2026.110747_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256972","article-title":"Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice","volume":"16","author":"Yue","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2026.110747_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2023.13120","article-title":"Autoimmune receptor encephalitis in ApoE\u2212\/\u2212 mice induced by active immunization with NMDA1","volume":"28","author":"Yu","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0720","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/brain\/awae410","article-title":"Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis","volume":"148","author":"Maudes","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1177672","article-title":"Optimizing animal models of autoimmune encephalitis using active immunization","volume":"14","author":"Linnoila","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0730","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-021-02107-0","article-title":"Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit","volume":"18","author":"Ding","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0735","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-023-02844-4","article-title":"Transfer of patient's peripheral blood mononuclear cells (PBMCs) disrupts blood-brain barrier and induces anti-NMDAR encephalitis: a study of novel humanized PBMC mouse model","volume":"20","author":"Shu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0740","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1038\/s41380-021-01238-3","article-title":"Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis","volume":"26","author":"Wilke","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0745","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0750","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0755","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","article-title":"Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited","volume":"71","author":"Steiner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0760","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/STROKEAHA.114.008323","article-title":"Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke","volume":"46","author":"Zerche","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2026.110747_bb0765","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-G\u00f3mez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0770","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.24545","article-title":"The brain as immunoprecipitator of serum autoantibodies against N-methyl-D-aspartate receptor subunit NR1","volume":"79","author":"Castillo-Gomez","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0775","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41380-017-0011-3","article-title":"Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model","volume":"24","author":"Pan","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0780","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1038\/s41380-021-01392-8","article-title":"NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance","volume":"27","author":"Arinrad","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0785","article-title":"The anti-NMDAR1 antibodies and IL-17 signaling pathway shape NMDAR encephalitis","author":"Xu","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb0790","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dmcn.12036","article-title":"Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis","volume":"55","author":"Dale","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577365","article-title":"Cerebrospinal fluid CD20 positive B-cell expansion in a case of anti-NMDAR encephalitis","volume":"349","author":"Zheng","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb0800","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/pcn.13627","article-title":"Single-cell RNA sequencing reveals diverse B cell phenotypes in patients with anti-NMDAR encephalitis","volume":"78","author":"Li","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.clim.2026.110747_bb0805","article-title":"Immunoregulatory programs in anti-N-methyl-D-aspartate receptor encephalitis identified by single-cell multi-omics analysis","volume":"15","author":"Li","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.clim.2026.110747_bb0810","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000732","article-title":"Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation","volume":"7","author":"Esaulova","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0815","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3389\/fimmu.2020.01539","article-title":"Study of B cell repertoire in patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"11","author":"Feng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0820","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.4049\/jimmunol.2300156","article-title":"VH2+ antigen-experienced B cells in the cerebrospinal fluid are expanded and enriched in pediatric anti-NMDA receptor encephalitis","volume":"211","author":"Monson","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0825","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00415-018-9042-1","article-title":"Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics","volume":"265","author":"Ly","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2024.05.034","article-title":"Antibody-secreting cells as a source of NR1-IgGs in N-methyl-D-aspartate receptor-antibody encephalitis","volume":"120","author":"Li","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.clim.2026.110747_bb0835","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717598","article-title":"Comprehensive B-cell immune repertoire analysis of anti-NMDAR encephalitis and anti-LGI1 encephalitis","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0845","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/brain\/awac088","article-title":"Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis","volume":"145","author":"Al-Diwani","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0850","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1007\/s10571-023-01371-3","article-title":"Inhibiting PI3K\/Akt-signaling pathway improves neurobehavior changes in anti-NMDAR encephalitis mice by ameliorating blood\u2013brain barrier disruption and neuronal damage","volume":"43","author":"Gong","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.clim.2026.110747_bb0855","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12974-023-02841-7","article-title":"Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood\u2013brain barrier disruption in anti-NMDA receptor encephalitis","volume":"20","author":"Chang","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0860","article-title":"Cytokine\/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: a systematic review and meta-analysis","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb0865","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12987-022-00392-2","article-title":"Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis","volume":"19","author":"Lai","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.clim.2026.110747_bb0870","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and safety of immunotherapeutic management of N-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0875","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-019-0693-7","article-title":"Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis","volume":"7","author":"Chefdeville","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.clim.2026.110747_bb0880","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2169\/internalmedicine.49.4069","article-title":"Expression of various glutamate receptors including N-methyl-D-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis","volume":"49","author":"Tachibana","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.clim.2026.110747_bb0885","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/acn3.51948","article-title":"Teratoma pathology and genomics in anti-NMDA receptor encephalitis","volume":"11","author":"Jang","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0890","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/pin.12732","article-title":"Histopathological characterization of the neuroglial tissue in ovarian teratoma associated with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis","volume":"68","author":"Iemura","year":"2018","journal-title":"Pathol. Int."},{"key":"10.1016\/j.clim.2026.110747_bb0895","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000353982","article-title":"Immunopathological significance of ovarian teratoma in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"71","author":"Tabata","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0900","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0000000000001249","article-title":"Ovarian Teratomas in women with anti-N-methyl-D-aspartate receptor encephalitis: topography and composition of immune cell and neuroglial populations is compatible with an autoimmune mechanism of disease","volume":"43","author":"Nolan","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.clim.2026.110747_bb0905","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","article-title":"NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias lecture","volume":"87","author":"Dalmau","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0910","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00415-013-7074-0","article-title":"Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma","volume":"260","author":"Mangler","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0915","doi-asserted-by":"crossref","first-page":"E1118","DOI":"10.21037\/jtd.2017.12.71","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis associated with mediastinal teratoma: a rare case report and literature review","volume":"9","author":"Li","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.clim.2026.110747_bb0920","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis associated with mediastinal and ovarian Teratomas: a case report","volume":"38","author":"Lee","year":"2023","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb0925","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.radcr.2020.08.010","article-title":"Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma","volume":"15","author":"Escudero-Fernandez","year":"2020","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0930","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti\u2013NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0935","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001127","article-title":"Anti-NMDAR encephalitis in the Netherlands, focusing on late-onset patients and antibody test accuracy","volume":"9","author":"Bastiaansen","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb0940","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0945","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0950","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002125","article-title":"Autoimmune post\u2013herpes simplex encephalitis of adults and teenagers","volume":"85","author":"Armangue","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0955","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/brain\/awad238","article-title":"Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies","volume":"146","author":"Armangu\u00e9","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0960","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1007\/s00415-024-12615-7","article-title":"Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis","volume":"271","author":"Dumez","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0965","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N -methyl- D -aspartate receptor antibodies in post\u2013herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clim.2026.110747_bb0970","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pr\u00fcss","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb0975","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcv.2018.04.007","article-title":"Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis","volume":"103","author":"Westman","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.clim.2026.110747_bb0980","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/brain\/awad419","article-title":"The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity","volume":"147","author":"Cleaver","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.clim.2026.110747_bb0985","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.94.15_supplement.475","article-title":"Case of concurrent herpes simplex encephalitis and leucine-rich glioma inactivated 1 encephalitis (475)","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb0990","article-title":"Contactin-associated protein-like 2 (CASPR2) antibody generation in acute herpes simplex encephalitis: case report and review of the literature","volume":"7","author":"Kim","year":"2025","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.clim.2026.110747_bb0995","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12883-022-02637-x","article-title":"Caspr2 antibodies in herpes simplex encephalitis: an extension of the spectrum of virus induced autoimmunity? \u2013 a case report","volume":"22","author":"Berek","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1000","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms18010193","article-title":"Anti-NMDA receptor encephalitis and vaccination","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb1005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14581\/jer.22013","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis after BNT162b2 COVID-19 vaccination","volume":"12","author":"Lee","year":"2022","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.clim.2026.110747_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.764197","article-title":"Acute psychosis due to anti-N-methyl D-aspartate receptor encephalitis following COVID-19 vaccination: a case report","volume":"12","author":"Flannery","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41398-024-02831-0","article-title":"Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis","volume":"14","author":"Vasilevska","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb1020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.940780","article-title":"Anti-NMDA receptor encephalitis and vaccination: a disproportionality analysis","volume":"13","author":"Martin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2026.110747_bb1025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2026.110747_bb1030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1474-4422(14)70041-9","article-title":"Multiple sclerosis genetics","volume":"13","author":"Sawcer","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clim.2026.110747_bb1040","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb1045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/WCO.0000000000001263","article-title":"Genetic predisposition to autoimmune encephalitis and paraneoplastic neurological syndromes","volume":"37","author":"Mu\u00f1iz-Castrillo","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1050","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clim.2026.110747_bb1055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"German network for research on autoimmune encephalitis (GENERATE), genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1423149","article-title":"HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis","volume":"15","author":"Peris Sempere","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb1065","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001085","article-title":"German network for research on autoimmune encephalitis (GENERATE), genome-wide association study identifies 2 new loci associated with anti-NMDAR encephalitis","volume":"8","author":"Tietz","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb1070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(23)00369-1","article-title":"Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes","volume":"23","author":"Farina","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1075","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/ene.15835","article-title":"Immune checkpoint inhibitor-associated central nervous system autoimmunity","volume":"30","author":"Valencia-Sanchez","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1080","doi-asserted-by":"crossref","first-page":"e2442","DOI":"10.1212\/WNL.0000000000010632","article-title":"Neurologic autoimmunity and immune checkpoint inhibitors","volume":"95","author":"Sechi","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb1085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2741\/4412","article-title":"Efficacies of treatments for anti-NMDA receptor encephalitis","volume":"21","author":"Wang","year":"2016","journal-title":"Front. Biosci."},{"key":"10.1016\/j.clim.2026.110747_bb1090","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1007\/s10072-023-07018-x","article-title":"Controversies in immunotherapy for anti-NMDA receptor encephalitis: a scoping review with a proposal of operational definitions","volume":"44","author":"Bandeira","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb1095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-025-13032-0","article-title":"German network for research on autoimmune encephalitis (GENERATE), intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2","volume":"272","author":"Rittel","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14737175.2025.2483925","article-title":"Current and emerging therapies for autoimmune encephalitis","volume":"25","author":"Dinov","year":"2025","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.clim.2026.110747_bb1105","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213537","article-title":"Diagnosis and Management of Children with Atypical Neuroinflammation","volume":"104","author":"Saucier","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb1110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nic.2012.12.009","article-title":"Anti-NMDA receptor encephalitis","volume":"23","author":"Jones","year":"2013","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.clim.2026.110747_bb1115","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1007\/s10072-025-08210-x","article-title":"Risk factors for poor response to initial first-line immunotherapy and subsequent immunotherapy on prognosis in pediatric anti-NMDA receptor encephalitis","volume":"46","author":"Li","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb1120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/acn3.50798","article-title":"Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis","volume":"6","author":"Wang","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1125","article-title":"Efficacy of rituximab as second-line therapy for autoimmune encephalitis: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.clim.2026.110747_bb1130","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1212\/CON.0000000000001464","article-title":"Pediatric autoimmune neurologic disorders","volume":"30","author":"Hacohen","year":"2024","journal-title":"Continuum"},{"key":"10.1016\/j.clim.2026.110747_bb1135","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200395","article-title":"Australian autoimmune encephalitis consortium, rituximab use for relapse prevention in anti-NMDAR antibody-mediated encephalitis: a multicenter cohort study","volume":"12","author":"Seery","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.clim.2026.110747_bb1140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.21873\/invivo.13858","article-title":"Precision assessment of anti-NMDA receptor encephalitis: a case report on integrating clinical course, Immunophenotyping, and comprehensive symptomatology in a pediatric patient with adjunctive hydrogen therapy","volume":"39","author":"Lin","year":"2025","journal-title":"In Vivo"},{"key":"10.1016\/j.clim.2026.110747_bb1145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ana.27218","article-title":"Efficacy and safety of Ofatumumab treatment for anti-NMDA receptor autoimmune encephalitis (OFF-AE): a prospective, multicenter cohort study","volume":"98","author":"Guo","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1150","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.0000000000208026","article-title":"Immunotherapy in autoimmune encephalitis: so many options, so few guidelines","volume":"101","author":"Srivastava","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2026.110747_bb1155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10072-020-04942-0","article-title":"Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature","volume":"42","author":"Nan","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2026.110747_bb1160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11606-011-1641-9","article-title":"Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition","volume":"26","author":"Day","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.clim.2026.110747_bb1165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1170","series-title":"FcRn Antagonists (Efgartigimod) for Acute Neuromyelitis Optica Spectrum Disorders (NMOSD) Attack: a Phase 2, Randomized Controlled Trial.","author":"Shi","year":"2024"},{"key":"10.1016\/j.clim.2026.110747_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104025","article-title":"Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar","volume":"66","author":"Yamamura","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clim.2026.110747_bb1180","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2026.110747_bb1185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00415-025-13485-3","article-title":"Efgartigimod-rituximab sequential therapy in anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy","volume":"272","author":"Tan","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123597","article-title":"Multicenter experience with Efgartigimod in the treatment of anti-NMDAR encephalitis compared with IVIG and SPA-IA during acute attacks","volume":"371","author":"Liu","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.clim.2026.110747_bb1195","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70534","article-title":"Safety and efficacy of a neonatal fc receptor antagonist in patients with anti-NMDAR encephalitis","volume":"31","author":"Bian","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clim.2026.110747_bb1200","series-title":"A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult and Adolescent Participants With Autoimmune Encephalitis","author":"Argenx","year":"2026"},{"key":"10.1016\/j.clim.2026.110747_bb1205","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X416346251202083137","article-title":"Systematic reviews and Meta-analyses of the use of tocilizumab in treating central nervous diseases","author":"Peng","year":"2026","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.clim.2026.110747_bb1210","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1437913","article-title":"Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)","volume":"15","author":"Lee","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110747_bb1215","article-title":"Combination therapy of ofatumumab and daratumumab in patients with severe anti-NMDA receptor encephalitis","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110747_bb1220","doi-asserted-by":"crossref","DOI":"10.1212\/WN9.0000000000000007","article-title":"A phase-2B double-blind randomized international prospective trial of Inebilizumab in NMDAR encephalitis: the ExTINGUISH trial","volume":"1","author":"Wong","year":"2025","journal-title":"Neurol. Open Access"},{"key":"10.1016\/j.clim.2026.110747_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577586","article-title":"Bortezomib in anti-N-methyl\u2011d-aspartate-receptor (NMDA-R) encephalitis: a systematic review","volume":"356","author":"Dinoto","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2026.110747_bb1230","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s13063-020-04516-7","article-title":"GENERATE study group, generate-boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis","volume":"21","author":"Wickel","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.clim.2026.110747_bb1235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clim.2026.110747_bb1240","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt0795","article-title":"Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis","volume":"11","author":"Oh","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.clim.2026.110747_bb1245","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.clim.2026.110747_bb1255","article-title":"Self-antigen driven affinity maturation is required for pathogenic monovalent IgG4 autoantibody development","author":"Fichtner","year":"2026","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:20:12Z","timestamp":1788045612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":250,"alternative-id":["S1521661626000859"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110747","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopathogenesis of NMDA receptor encephalitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110747"}}